Pan African Medical Journal · 2020 · 98 citations · 0 references
MedicineInfectious DiseasesMolecular MedicineMolecular DiagnosticsMolecular VirologyVirologyDiagnostic Test EvaluationInfectious Disease DetectionInfectious Disease Molecular TestingPathogen DetectionRapid Diagnostic TestsViral DiagnosticsCoronavirus DiagnosticsDiagnostic Assay DevelopmentPolymerase Chain Reaction (Pcr) AssaysPolymerase Chain Reaction (Pcr) DiagnosisPolymerase Chain Reaction (Pcr) DiagnosticsReal-time Polymerase Chain Reaction (Pcr)Real-time Polymerase Chain Reaction AssaysSars-cov-2 Infection
COVID-19 impacts global public health, economy, education, tourism/hospitality and sports; rapid and accurate testing of clinical samples dictate effective response. So far, the real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) is the assay of choice for COVID-19 diagnosis considering its rapidity and accuracy in informing on active coronavirus (CoV) infection. Presently, several RT-qPCR protocols with differing sensitivity/specificity are used for performing this assay; some of them are known to have generated debatable test results to constitute challenges worthy of consideration its use. This review provides a critical assessment of various published works on RT-qPCR assays used for COVID-19 diagnosis with their different indicators of positivity i.e., cycle threshold (Ct) cut-off values. Knowledge of diagnostic tests for COVID-19 is still evolving and, as a prospect, underscores the need for local validation of positive-negative Ct cut-off values when establishing RT-qPCR assays for SARS-CoV-2 detection.